Although some of them are marketable, there are dozens of vaccines against the coronavirus in development all over the world.
Some use proven technologies, other employee new features. All vacancies have different form tests, some are allowed to enter operation including those that have been rigorously tested.
Its efficiency varies, and the results of preliminary studies oscillate between 50% and more than 90%.
Hasta now, the regulators of distant lands have allowed the use of a media dozen of them, the majority in respect of dispositions of emergency use.
Some are more at the point of hacerlo. All those that are available now require doses, administered with differentiation weeks.
Continuation, some of the most advanced vacancies:
–Pfizer: Desarrollada with BioNTech; Authorized by United States, United Kingdom, European Union, World Health Organization and other countries.
–Modern: Developed with the National Institutes of Health of the United States; authorized by the United States, the United Kingdom, the European Union, the World Health Organization and other countries.
–AstraZeneca: Developed at Oxford University; Authorized for more than 40 countries, including the United Kingdom, India, Argentina, Mexico and the European Union.
–Sputnik V: Developed by the Gamaleya Russia Investigation Institute; authorized by Russia, Argentina and Bolivia, between one dozen countries.
–Sinofarm: Authorized in China and some other countries, such as Hungary, Serbia and Morocco.
–Sinovac: Authorized in China, as well as in Turkey, Brazil and Indonesia.
–Bharat Biotech: Authorized in India.
–Johnson & Johnson: En desarrollo; a dose; it is hoped that the application will be submitted to the Authorization of the Food and Drug Administration of the United States.
–Novavax: In development.